» Articles » PMID: 35518307

A Signal-enhanced and Sensitive Lateral Flow Aptasensor for the Rapid Detection of PDGF-BB

Overview
Journal RSC Adv
Specialty Chemistry
Date 2022 May 6
PMID 35518307
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet-derived growth factor BB (PDGF-BB) is a potential biomarker of tumor angiogenesis. For the first time, we developed a highly sensitive aptasensor for PDGF-BB with an enhanced test line signal by using two different gold nanoparticles (AuNPs). Herein, we describe a highly sensitive biosensor for PDGF-BB detection that combines biotinylated aptamer on a sample pad and poly thymine-Cy3-AuNP-monoclonal antibody complexes against PDGF-BB immobilized on conjugate pad A. Streptavidin (SA) and rabbit anti-mouse polyclonal antibody were also immobilized in the nitrocellulose membrane at the test and control zones, respectively. When the target PDGF-BB protein was added, it first bound the aptamer, and later the monoclonal antibody to form a biotinylated complex that was captured by SA, resulting in a visual red line on the test zone. In addition, to enhance the sensitivity, another monoclonal antibody against Cy3 was conjugated on AuNP B and immobilized on conjugate pad B to form a AuNPs (A&B)-antibody-(PDGF-BB-Cy3)-aptamer-biotin-SA complex on the test line when a loading buffer was subsequently added. This approach showed a linear response to PDGF-BB from 3 ng mL to 300 ng mL with a limit of detection as low as 1 ng mL obtained in 10 minutes. Our biosensor displayed results through red lines readable by the naked eye. Interestingly, our approach has been successfully applied for real sample verification, proving its applicability for cancer monitoring and diagnosis.

Citing Articles

Review on the Selection of Aptamers and Application in Paper-Based Sensors.

Wang K, Wang M, Ma T, Li W, Zhang H Biosensors (Basel). 2023; 13(1).

PMID: 36671874 PMC: 9856030. DOI: 10.3390/bios13010039.


Current Advances in Paper-Based Biosensor Technologies for Rapid COVID-19 Diagnosis.

Kim S, Lee J Biochip J. 2022; 16(4):376-396.

PMID: 35968255 PMC: 9363872. DOI: 10.1007/s13206-022-00078-9.


Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis.

Wang T, Chen L, Chikkanna A, Chen S, Brusius I, Sbuh N Theranostics. 2021; 11(11):5174-5196.

PMID: 33859741 PMC: 8039946. DOI: 10.7150/thno.56471.

References
1.
Leitzel K, BRYCE W, Tomita J, Manderino G, TRIBBY I, Thomason A . Elevated plasma platelet-derived growth factor B-chain levels in cancer patients. Cancer Res. 1991; 51(16):4149-54. View

2.
Yang L, Fu C, Wang H, Xu S, Xu W . Aptamer-based surface-enhanced Raman scattering (SERS) sensor for thrombin based on supramolecular recognition, oriented assembly, and local field coupling. Anal Bioanal Chem. 2016; 409(1):235-242. DOI: 10.1007/s00216-016-9992-z. View

3.
Qu F, Lu H, Yang M, Deng C . Electrochemical immunosensor based on electron transfer mediated by graphene oxide initiated silver enhancement. Biosens Bioelectron. 2011; 26(12):4810-4. DOI: 10.1016/j.bios.2011.06.018. View

4.
Kolpashchikov D, Stojanovic M . Boolean control of aptamer binding states. J Am Chem Soc. 2005; 127(32):11348-51. DOI: 10.1021/ja051362f. View

5.
Zhang Z, Guo C, Zhang S, He L, Wang M, Peng D . Carbon-based nanocomposites with aptamer-templated silver nanoclusters for the highly sensitive and selective detection of platelet-derived growth factor. Biosens Bioelectron. 2016; 89(Pt 2):735-742. DOI: 10.1016/j.bios.2016.11.019. View